PATTERNS OF SURGICAL CARE OF LUNG CANCER PATIENTS

REFERENCES
1. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung
cancer patients. Ann Thorac Surg 2005;80:2051–2056.
2. Osaki T, Oyama T, Gu CD, et al. Prognostic impact of micrometastatic
tumor cells in the lymph nodes and bone marrow of patients with
completely resected stage I non-small-cell lung cancer. J Clin Oncol
2002;20:2930–2936.
3. Wu J, Ohta Y, Minato H, et al. Nodal occult metastasis in patients with
peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann
Thorac Surg 2001;71:1772–1777.
4. Maddaus M, Wang X, Vollmer R, et al. CALGB 9761: a prospective
analysis of IHC and PCR based detection of occult metastatic disease
in stage I NSCLC. ASCO Annual Meeting Proceedings Part I, 2006.
J Clin Oncol 2006;24:7030.
5. Detterbeck F, Jantz M, Wallace M, et al. Invasive mediastinal staging of
lung cancer: an ACCP evidence-based clinical practice guideline (2nd
edition). Chest 2007;132:202S–220S.
6. Silvestri G, Gould MK, Margolis ML, et al. Non-invasive staging of
non-small cell lung cancer: ACCP evidenced-based clinical practice
guidelines (2nd edition). Chest 2007;132:178S–201S.
7. Cybulsky IJ, Bennett WF. Mediastinoscopy as a routine outpatient
procedure. Ann Thorac Surg 1994;58:176–178.
8. Vallières E, Pagé A, Verdant A. Ambulatory mediastinoscopy and anterior
mediastinotomy. Ann Thorac Surg 1991;52:1122–1126.
9. Selby JH Jr, Leach CL, Heath BJ, et al. Local anesthesia for mediastinoscopy:
experience with 450 consecutive cases. Am Surg 1978;44:
679–682.
10. Kiser AC, Detterbeck FC. General aspects of surgical treatment. In:
Detterbeck FC, Rivera MP, Socinski MA, et al., eds. Diagnosis and
Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing
Clinician . Philadelphia, PA: WB Saunders, 2001:133–147.
11. Detterbeck FC, Jones DR, Parker LA Jr. Intrathoracic staging. In:
Detterbeck FC, Rivera MP, Socinski MA, et al., eds. Diagnosis and
Treatment of Lung Cancer: An Evidence-Based Guide for the Practicing
Clinician . Philadelphia: WB Saunders, 2001:73–93.
12. Coughlin M, Deslauriers J, Beaulieu M, et al. Role of mediastinoscopy
in pretreatment staging of patients with primary lung cancer. Ann
Thorac Surg 1985;40:556–560.
13. Staples CA, Müller NL, Miller RR, et al. Mediastinal nodes in bronchogenic
carcinoma: comparison between CT and mediastinoscopy.
Radiology 1988;167:367–372.
14. Gdeedo A, Van Schil P, Corthouts B, et al. Prospective evaluation of
computed tomography and mediastinoscopy in mediastinal lymph
node staging. Eur Respir J 1997;10:1547–1551.
15. Van den Bosch JM, Gelissen HJ, Wagenaar SS. Exploratory thoracotomy
in bronchial carcinoma. J Thorac Cardiovasc Surg 1983;85:733–737.
16. Hammoud ZT, Anderson RC, Meyers BF, et al. The current role of mediastinoscopy
in the evaluation of thoracic disease. J Thorac Cardiovasc
Surg 1999;118:894–899.
17. Lardinois D, Schallberger A, Betticher D, et al. Postinduction videomediastinoscopy
is as accurate and safe as video-mediastinoscopy in
patients without pretreatment for potentially operable non-small cell
lung cancer. Ann Thorac Surg 2003;75:1102–1106.
18. Smulders SA, Smeenk FW, Janssen-Heijnen ML, et al. Surgical mediastinal
staging in daily practice. Lung Cancer 2005;47:243–251.
19. Bach PB, Cramer LD, Schrag D, et al. The influence of hospital volume
on survival after resection for lung cancer. N Engl J Med 2001;
345:181–188.
20. Silvestri GA, Handy J, Lackland D, et al. Specialists achieve better outcomes
than generalists for lung cancer surgery. Chest 1998;114:675–680.
21. Hillner BE, Smith TJ, Desch CE. Hospital and physician volume or
specialization and outcomes in cancer treatment: importance in quality
of cancer care. J Clin Oncol 2000;18:2327–2340.
22. Detterbeck F. What to do with “surprise” N2: intraoperative management
of patients with non-small cell lung cancer. J Thorac Oncol
2008;3:289–302.
23. Detterbeck F, Falen S, Rivera M, et al. Seeking a home for a PET, part
2: defining the appropriate place for positron emission tomography
imaging in the staging of patients with suspected lung cancer. Chest
2004;125:2300–2308.
24. Gonzalez–Stawinski GV, Lemaire A, Merchant F, et al. A comparative
analysis of positron emission tomography and mediastinoscopy
in staging non-small cell lung cancer. J Thorac Cardiovasc Surg
2003;126:1900–1905.
25. Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron
emission tomography and computed tomography for mediastinal
staging in patients with non-small-cell lung cancer: a meta-analysis.
Ann Intern Med 2003;139:879–892.
26. De Leyn P, Lardinois D, Van Schil P, et al. ESTS guidelines for preoperative
lymph node staging for non-small cell lung cancer. Eur J
Cardiothorac Surg 2007;32:1–8.
27. Venissac N, Alifano M, Mouroux J. Video-assisted mediastinoscopy: experience
from 240 consecutive cases. Ann Thorac Surg 2003;76:208–212.
28. Kimura H, Iwai N, Ando S, et al. A prospective study of indications
for mediastinoscopy in lung cancer with CT findings, tumor size, and
tumor markers. Ann Thorac Surg 2003;75:1734–1739.
29. Witte B, Wolf M, Huertgen M, et al. Video-assisted mediastinoscopic
surgery: clinical feasibility and accuracy of mediastinal lymph node
staging. Ann Thorac Surg 2006;82:1821–1827.
30. Leschber G, Holinka G, Linder A. Video-assisted mediastinoscopic
lymphadenectomy (VAMLA):a method for systematic mediastinal
lymph node dissection. Eur J Cardiothorac Surg 2003;24:192–195.
31. Hurtgen M, Friedel G, Toomes H, et al. Radical video-assisted mediastinoscopic
lymphadenectomy (VAMLA):technique and first results.
Eur J Cardiothorac Surg 2002;21:348–351.
32. Zieli´nski M. Transcervical extended mediastinal lymphadenectomy:
results of staging in two hundred fifty-six patients with non-small cell
lung cancer. J Thorac Oncol 2007;2:370–372.
33. Kuzdzal J, Zielinski M, Papla B, et al. Transcervical extended mediastinal
lymphadenectomy—the new operative technique and early results
in lung cancer staging. Eur J Cardiothorac Surg 2005;27:384–390.
34. Kuzdzal J, Zielinski M, Papla B, et al. The transcervical extended mediastinal
lymphadenectomy versus cervical mediastinoscopy in non-small
cell lung cancer staging. Eur J Cardiothorac Surg 2007;31:88–94.
35. Cerfolio RJ, Bryant AS, Eloubeidi MA. Accessing the aortopulmonary
window (#5) and the para-aortic (#6) lymph nodes in patients with
non-small cell lung cancer. Ann Thorac Surg 2007;84:940–945.
36. Sebastian–Quetglas F, Molins L, et al. Clinical value of video-assisted
thoracoscopy for preoperative staging of non-small cell lung cancer: a
prospective study of 105 patients. Lung Cancer 2003;42:297–301.
37. Eggeling S, Martin T, Bottger J, et al. Invasive staging of nonsmall
cell lung cancer: a prospective study. Eur J Cardiothorac Surg
2002;22:679–684.
38. Landreneau RJ, Hazelrigg SR, Mack MJ, et al. Thoracoscopic mediastinal
lymph node sampling: useful for mediastinal lymph node stations
inaccessible by cervical mediastinoscopy. J Thorac Cardiovasc Surg
1993;106:554–558.
39. Massone PP, Lequaglie C, Magnani B, et al. The real impact and usefulness
of video-assisted thoracoscopic surgery in the diagnosis and
therapy of clinical lymphadenopathies of the mediastinum. Ann Surg
Oncol 2003;10:1197–1202.
40. Roberts JR, Blum MG, Arildsen R, et al. Prospective comparison of
radiologic, thoracoscopic, and pathologic staging in patients with early
non-small cell lung cancer. Ann Thorac Surg 1999;68:1154–1158.
41. Detterbeck F. Integration of mediastinal staging techniques for lung
cancer. Semin Thorac Cardiovasc Surg 2007;19:217–224.
42. Boyer M, Viney R, Fulham M, et al. A randomised trial of conventional
staging with or without positron emission tomography (PET) in
patients with stage 1 or 2 non-small cell lung cancer (NSCLC). ASCO
Proc 2001;20:309a.
43. Farrell MA, McAdams HP, Herndon JE, et al. Non-small cell lung
cancer: FDG PET for nodal staging in patients with stage I disease.
Radiology 2000;215:886–890.
44. Leslie A, Jones AJ, Goddard PR. The influence of clinical informa tion on
the reporting of CT by radiologists. Br J Radiol 2000;73:1052–1055.
45. Smulders S, Gundy C, van Lingen A, et al. Observer variation of
2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography in
mediastinal staging of non-small cell lung cancer as a function of experience,
and its potential clinical impact. Mol Imaging Biol 2007;9:
318–322.
46. Brehmer B. In one word: not from experience. Acta Psychologica
1980;45:223–241.
47. Serra M, Cirera L, Rami-Porta R, et al. Routine positron emission tomography
(PET) and selective mediastinoscopy is as good as routine
mediastinoscopy to rule out N2 disease in non-small cell lung cancer
(NSCLC). J Clin Oncol 2006;24(No. 18S Part I of II):S371.
48. Cerfolio RJ, Bryant AS, Ojha B, et al. Improving the inaccuracies of
clinical staging of patients with NSCLC: a prospective trial. Ann Thorac
Surg 2005;80:1207–1214.
49. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDGPET
for the management of potentially operable non-small cell lung
cancer; priority for a PET-based strategy after nodal-negative CT results.
Eur J Nucl Med 2000;27:1598–1609.
50. Patterson GA, Piazza D, Pearson FG, et al. Significance of metastatic
disease in subaortic lymph nodes. Ann Thorac Surg 1987;43:155–159.
51. Detterbeck FC, Jones DR. Surgical treatment of stage IIIa (N2)
non-small cell lung cancer. In: Detterbeck FC, Rivera MP, Socinski
MA, et al., eds. Diagnosis and Treatment of Lung Cancer: An Evidence-
Based Guide for the Practicing Clinician . Philadelphia: WB Saunders,
2001:244–256.
52. Jiao J, Magistrelli P, Goldstraw P. The value of cervical mediastinoscopy
combined with anterior mediastinotomy in the peroperative evaluation
of bronchogenic carcinoma of the left upper lobe. Eur J Cardiothorac
Surg 1997;11:450–454.
53. Best LA, Munichor M, Ben-Shakhar M, et al. The contribution of anterior
mediastinotomy in the diagnosis and evaluation of diseases of the
mediastinum and lung. Ann Thorac Surg 1987;43:78–81.
54. Ginsberg RJ, Rice TW, Goldberg M, et al. Extended cervical mediastinoscopy:
a single staging procedure for bronchogenic carcinoma of the
left upper lobe. J Thorac Cardiovasc Surg 1987;94:673–678.
55. Freixinet Gilart J, Gámez-Garcia P, Rodríguez de Castro F, et al.
Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma.
Ann Thorac Surg 2000;70:1641–1643.
56. Urschel JD, Vretenar DF, Dickout WJ, et al. Cerebrovascular accident
complicating extended cervical mediastinoscopy. Ann Thorac Surg
1994;57:740–741.
57. Lopez L, Varela A, Freixinet J, et al. Extended cervical mediastinoscopy:
prospective study of fifty cases. Ann Thorac Surg 1994;57:555–558.
58. Ginsberg RJ. In discussion of: Lopez L, Varela A, Freixinet J, et al.
Extended cervical mediastinoscopy: prospective study of fifty cases.
Ann Thorac Surg 1994;57:557–558.
59. Scott W, Howington J, Feigenberg S, et al. Treatment of non-small
cell lung cancer - stage I & II: ACCP evidence-based clinical practice
guideline (2nd ed). Chest 2007;132:234S–242S
60. Lardinois D, De Leyn P, Van Schil P, et al. ESTS guidelines for intraoperative
lymph node staging in non-small cell lung cancer. Eur J
Cardiothorac Surg 2006;30:787–792.
61. Bollen EC, van Duin CJ, Theunissen PH, et al. Mediastinal lymph
node dissection in resected lung cancer: morbidity and accuracy of
staging. Ann Thorac Surg 1993;55:961–966.
62. Gaer JA, Goldstraw P. Intraoperative assessment of nodal staging at
thoracotomy for carcinoma of the bronchus. Eur J Cardiothorac Surg
1990;4:207–210.
63. Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic
nodal dissection in resectable non-small cell lung cancer. Lung Cancer
2002;36:1–6.
64. Izbicki JR, Passlick B, Karg O, et al. Impact on radical systematic mediastinal
lymphadenectomy on tumor staging in lung cancer. Ann
Thorac Surg 1995;59:209–214.
65. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of
major pulmonary resections in patients with early-stage lung cancer:
initial results of the randomized, prospective ACOSOG Z0030 Trial.
Ann Thorac Surg 2006;81:1013–1020.
66. Magnanelli G, Scanagatta P, Benato C, et al. Is sampling really effective
in staging non-small cell lung cancer? A prospective study. Chir Ital
2006;58:19–22.
67. Keller SM, Adak S, Wagner H, et al. Mediastinal lymph node dissection
improves survival in patients with stages II and IIIa non-small
cell lung cancer; from the Eastern Cooperative Oncology Group. Ann
Thorac Surg 2000;70:358–365.
68. Sugi K, Nawata K, Fujita N, et al. Systematic lymph node dissection
for clinically diagnosed peripheral non-small-cell lung cancer less than
2 cm in diameter. World J Surg 1998;22:290–294.
69. Izbicki JR, Thetter O, Habekost M, et al. Radical systematic mediastinal
lymphadenectomy in non-small cell lung cancer: a randomized
controlled trial. Br J Surg 1994;81:229–235.
70. Funatsu T, Matsubara Y, Ikeda S, et al. Preoperative mediastinoscopic
assessment of N factors and the need for mediastinal lymph node dissection
in T1 lung cancer. J Thorac Cardiovasc Surg 1994;108:321–328.
71. Luke WP, Pearson FG, Todd TR, et al. Prospective evaluation of mediastinoscopy
for assessment of carcinoma of the lung. J Thorac Cardiovasc
Surg 1986;91:53–56.
72. De Leyn P, Schoonooghe P, Deneffe G, et al. Surgery for non-small cell
lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal
nodes (N2 disease). Eur J Cardiothorac Surg 1996;10:649–655.
73. Brion JP, Depauw L, Kuhn G, et al. Role of computed tomography and
mediastinoscopy in preoperative staging of lung carcinoma. J Computer
Assist Tomogr 1985;9:480–484.
74. Jolly PC, Hutchinson CH, Detterbeck F, et al. Routine computed tomographic
scans, selective mediastinoscopy, and other factors in evaluation
of lung cancer. J Thorac Cardiovasc Surg 1991;102:266–271.
75. Ratto GB, Frola C, Cantoni S, et al. Improving clinical efficacy of
computed tomographic scan in the preoperative assessment of patients
with non-small cell lung cancer. J Thorac Cardiovasc Surg 1990;
99:416–425.
76. Ebner H, Marra A, Butturini E, et al. Clinical value of cervical mediastinoscopy
in the staging of bronchial carcinoma. Ann Ital Chir
1999;70:873–879.
77. Deneffe G, Lacquet L, Gyselen A. Cervical mediastinoscopy and anterior
mediastinotomy in patients with lung cancer and radiologically
normal mediastinum. Eur J Respir Dis 1983;64:613–619.
78. Aaby C, Kristensen S, Nielsen SM. Mediastinal staging of non-smallcell
lung cancer: computed tomography and cervical mediastinoscopy.
ORL J Otorhinolaryngol Relat Spec 1995;57:279–285.
79. Page A, Nakhle G, Mercier C, et al. Surgical treatment of bronchogenic
carcinoma: the importance of staging in evaluating late survival. Ca J
Surg 1987;30:96–99.
80. Dillemans B, Deneffe G, Verschakelen J, et al. Value of computed tomography
and mediastinoscopy in preoperative evaluation of mediastinal
nodes in non-small cell lung cancer: a study of 569 patients. Eur J
Cardiothorac Surg 1994;8:37–42.
81. Riordan D, Buckley D, Aherne T. Mediastinoscopy as a predictor of
resectability in patients with bronchogenic carcinoma. Ir J Med Sci
1997;160:291–292.
82. Choi YS, Shim YM, Kim J, et al. Mediastinoscopy in patients with clinical
stage I non-small cell lung cancer. Ann Thorac Surg 2003;75:364–366.
83. Gürses A, Turna A, Bedirhan M, et al. The value of mediastinoscopy
in preoperative evaluation of mediastinal involvement in non-small-cell
lung cancer patients with clinical NO disease. Thorac Cardiovasc Surg
2002;50:174–177.